PMID: 8847557Mar 1, 1996

Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features

Journal of Neuro-oncology
David Schiff

Abstract

We reviewed the clinical features and risk factors for Pneumocystis carinii pneumonia (PCP) in patients with brain tumors (BTs) seen at our institution between 1980 and 1992. Previously rare, this opportunistic infection appears to be increasing among HIV-negative cancer patients receiving immunosuppressive medications. Recent reports have noted PCP among BT patients receiving corticosteroids, and suggested that these patients are particularly likely to develop PCP when corticosteroids are tapered. Nine BT patients, eight with high-grade gliomas, experienced ten episodes of PCP. None were known HIV-positive. All were on dexamethasone (DXM) at PCP onset, and had continuously been receiving it for 47-398 days (median 69). Daily DXM dose at PCP onset ranged from 1-16 mg (median 9). Five episodes occurred in patients receiving a stable DXM dose and five during DXM taper. Nine episodes occurred in patients receiving chemotherapy. All patients had absolute lymphopenia at PCP onset, ranging from 80-900 x 10(6) lymphocytes/l (median 222 x 10(6)/l, normal > 1000 x 10(6). Three episodes were fatal despite appropriate antibiotic therapy. Unlike others, we did not find that corticosteroid taper predisposed to developing PCP. As in HIV, PCP...Continue Reading

References

Nov 5, 1997·Clinics in Chest Medicine·G F Keenan
Apr 3, 2003·Cancer Treatment Reviews·Beela S Mathew, Stuart A Grossman
Apr 25, 2012·Japanese Journal of Clinical Oncology·Hiroki HayashiAkihiko Gemma
May 1, 2002·Current Opinion in Oncology·Patrick Y Wen, Peter W Marks
Aug 2, 2005·Neuro-oncology·Steven BremNew Approaches to Brain Tumor Therapy CNS Consortium
Dec 24, 2013·Mediators of Inflammation·Felinda ArianiJieming Qu
Aug 15, 2009·Expert Opinion on Investigational Drugs·Jennifer A MoliternoSusan C Pannullo
Feb 24, 2001·The American Journal of the Medical Sciences·D A Russian, S J Levine
Aug 29, 2012·Critical Reviews in Oncology/hematology·Filip Y De VosCarla M van Herpen
Jul 17, 2012·Hematology/oncology Clinics of North America·Jill LacyJames B Yu
Jun 12, 2010·Water Research·Edward PeltierDavid W Graham
Oct 30, 2007·Neurologic Clinics·Jan DrappatzPatrick Y Wen
Nov 23, 2006·Hematology/oncology Clinics of North America·Tracy T Batchelor, Thomas N Byrne
Jul 18, 2002·Dermatologic Clinics·Jennifer R Stalkup, Suneel Chilukuri
Jul 6, 2015·Current Treatment Options in Oncology·Jeffrey J Raizer, Karan S Dixit
Nov 2, 2014·Neuro-oncology·David SchiffPatrick Y Wen
May 28, 2016·CNS Oncology·Adrian G Murphy, Stuart A Grossman
Jul 20, 2012·Continuum : Lifelong Learning in Neurology·Jan Drappatz
Jul 24, 2001·Medical and Pediatric Oncology·A PoulsenK Schmiegelow
Mar 20, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Subbulaxmi Trikudanathan, Graham T McMahon
Feb 11, 2012·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Goh Ohji
Dec 5, 2017·Continuum : Lifelong Learning in Neurology·Nimish A Mohile
Jun 15, 2011·Expert Review of Clinical Pharmacology·Jörg DietrichSantosh Kesari
May 8, 2002·CNS Drugs·Phillip Davey
Jul 1, 2020·Current Neurology and Neuroscience Reports·David Schiff, Mossaed Alyahya
Aug 1, 2020·Current Treatment Options in Oncology·Karan S Dixit, Priya U Kumthekar
Jun 30, 2006·Journal of Neuro-oncology·Patrick Y WenLisa Doherty

Citations

Jan 1, 1978·The American Journal of the Medical Sciences·D H Lawson, H Jick
Dec 29, 1977·The New England Journal of Medicine·W T HughesS L George
Mar 1, 1976·Annals of Internal Medicine·A S FauciJ E Balow
Dec 24, 1992·The New England Journal of Medicine·H Masur
Feb 12, 1992·JAMA : the Journal of the American Medical Association·K A SepkowitzD Armstrong
Apr 1, 1991·Archives of Neurology·J W HensonA O Fels
Nov 15, 1989·Annals of Internal Medicine·H MasurJ C Edman
Jun 25, 1987·The New England Journal of Medicine·W T HughesL Lott
Jul 4, 1987·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·P S Pincus, S Zwi
Mar 1, 1984·Journal of Clinical Immunology·B ZweimanR P Lisak
Aug 21, 1980·The New England Journal of Medicine·R H Rubin, M N Swartz
Jul 1, 1980·American Journal of Diseases of Children·R B WilberW T Hughes
Mar 1, 1982·Reviews of Infectious Diseases·D H Lawson, B J Paice
Feb 1, 1993·The American Journal of Medicine·A SlivkaJ S Loeffler

Related Concepts

Corticosteroid-Binding Globulin Deficiency
Lymphocytes as Percentage of Blood Leukocytes (Lab Test)
Lymphopenia
Corticosteroid [EPC]
Neoplasms
Pneumocystis Infections
Corticosteroids, topical for treatment of hemorrhoids and anal fissures
Adrenal Cortex Hormones
Mixed Gliomas
Pneumocystis Jiroveci Pneumonia

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.